American cutaneous leishmaniasis.
This review outlines the present knowledge of American cutaneous leishmaniasis, a disease which, owing to the increase in international travel, is being seen with increasing frequency in Europe and North America. A knowledge of this disease is of particular importance to the military medical officer as in recent years approximately one-hundred and fifty cases of leishmaniasis have been seen in British troops who have served in Belize. Leishmania braziliensis sp. have been isolated from a number of these cases. Organisms of this complex had not previously been recorded in Belize and the Army Medical Services are therefore in a unique position to study this disease, as well as having a responsibility to ensure its correct management.
D000965:Antimony / Q000627:therapeutic use; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D000977:Antiparasitic Agents; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001531:Belize; D002489:Central America; D003937:Diagnosis, Differential; D006801:Humans; D007896:Leishmaniasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D008536:Meglumine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008887:Military Medicine; D012876:Skin Diseases, Parasitic / Q000175:diagnosis / Q000453:epidemiology*; D013020:South America; D006113:United Kingdom
D000977:Antiparasitic Agents; D000981:Antiprotozoal Agents; C006601:antimony-N-methylglucamine; D008536:Meglumine; D000965:Antimony; D000967:Antimony Sodium Gluconate